Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-03 Sale |
2022-06-06 4:46 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
1,123 | $11.54 | $12,956 | 65,421 (Direct) |
View |
2022-06-03 Sale |
2022-06-06 4:45 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
1,527 | $11.54 | $17,617 | 82,667 (Direct) |
View |
2022-05-09 Sale |
2022-05-11 4:15 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
297 | $13.11 | $3,895 | 66,544 (Direct) |
View |
2021-08-09 Sale |
2022-04-04 4:30 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
1,545 | $26.61 | $41,115 | 66,841 (Direct) |
View |
2022-03-03 Sale |
2022-03-07 4:15 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
403 | $17.33 | $6,983 | 68,386 (Direct) |
View |
2022-03-03 Sale |
2022-03-07 4:15 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER |
767 | $17.33 | $13,290 | 84,194 (Direct) |
View |
2022-02-08 Sale |
2022-02-10 4:36 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
302 | $17.63 | $5,323 | 31,196 (Direct) |
View |
2022-01-11 Sale |
2022-01-13 4:17 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer |
1,744 | $25.7 | $44,821 | 31,462 (Direct) |
View |
2022-01-03 Sale |
2022-01-04 4:23 pm |
Editas Medicine Inc. | EDIT | MULLEN JAMES C CEO |
18,252 | $26.95 | $491,979 | 75,898 (Direct) |
View |
2021-11-12 Sale |
2021-11-15 4:26 pm |
Editas Medicine Inc. | EDIT | Michaels Lisa Anne EVP/Chief Medical Officer |
1,568 | $38.33 | $60,101 | 18,432 (Direct) |
View |
2021-11-09 Sale |
2021-11-10 6:52 pm |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, Chief Business Officer |
287 | $40.61 | $11,655 | 28,026 (Direct) |
View |
2021-10-18 Sale |
2021-10-20 4:16 pm |
Editas Medicine Inc. | EDIT | MULLEN JAMES C CEO |
13,805 | $38.03 | $525,033 | 57,673 (Direct) |
View |
2021-08-09 Sale |
2021-08-10 4:33 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer |
2,500 | $60 | $150,000 | 143,735 (Direct) |
View |
2021-06-28 Sale |
2021-06-30 4:11 pm |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer |
2,500 | $50 | $125,000 | 146,235 (Direct) |
View |
2021-03-03 Purchase |
2021-03-05 4:13 pm |
Editas Medicine Inc. | EDIT | Hopfield Jessica Director |
5,800 | $45.51 | $263,970 | 22,700 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-06-02 Option Award |
2022-06-06 4:44 pm |
N/A 2032-06-01 |
Editas Medicine Inc. | EDIT | O'Neill Gilmore Neil CEO |
1,036,864 | $0 | 1,036,864 (Direct) |
View |
2022-04-14 Option Award |
2022-04-18 4:15 pm |
N/A 2031-03-01 |
Editas Medicine Inc. | EDIT | MULLEN JAMES C CEO |
170,989 | $0 | 170,989 (Direct) |
View |
2022-02-10 Option Award |
2022-02-11 4:22 pm |
N/A 2032-02-09 |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, CHIEF BUSINESS OFFICER |
148,325 | $0 | 179,521 (Direct) |
View |
2022-02-10 Option Award |
2022-02-11 4:21 pm |
N/A 2032-02-09 |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, CHIEF SCIENTIFIC OFFICER |
125,107 | $0 | 166,892 (Direct) |
View |
2022-02-10 Option Award |
2022-02-11 4:20 pm |
N/A 2032-02-09 |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE CHIEF FINANCIAL OFFICER |
211,079 | $0 | 242,541 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 4:11 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, Chief Business Officer |
3,472 | $0 | 31,498 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 4:10 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Michaels Lisa Anne EVP/Chief Medical Officer |
4,243 | $0 | 22,675 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 4:10 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer |
9,084 | $0 | 41,785 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 4:09 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer |
4,471 | $0 | 33,206 (Direct) |
View |
2021-12-22 Option Award |
2021-12-23 4:09 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | MULLEN JAMES C CEO |
36,477 | $0 | 94,150 (Direct) |
View |
2021-10-26 Option Award |
2021-10-28 4:13 pm |
N/A 2031-10-25 |
Editas Medicine Inc. | EDIT | Connaughton Bernadette Director |
24,732 | $0 | 24,732 (Direct) |
View |
Ownership |
2021-10-28 4:11 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Connaughton Bernadette Director |
0 | $0 | 0 (Direct) |
View |
2021-09-30 Option Award |
2021-10-04 4:20 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | MULLEN JAMES C CEO |
36,478 | $0 | 71,478 (Direct) |
View |
2021-09-03 Option Award |
2021-09-08 4:33 pm |
N/A 2031-09-02 |
Editas Medicine Inc. | EDIT | Reeve Emma Director |
13,736 | $0 | 13,736 (Direct) |
View |
Ownership |
2021-09-08 4:28 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Reeve Emma Director |
0 | $0 | 0 (Direct) |
View |
2021-08-09 Exercise |
2021-08-10 4:33 pm |
N/A 2030-01-08 |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer |
2,500 | $0 | 143,735 (Direct) |
View |
2021-08-09 Exercise |
2021-08-10 4:33 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer |
2,500 | $30.65 | 143,735 (Direct) |
View |
Ownership |
2021-07-30 4:11 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Eaton Bruce EVP, Chief Business Officer |
0 | $0 | 249,203 (Direct) |
View |
2021-06-28 Exercise |
2021-06-30 4:11 pm |
N/A 2030-01-08 |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer |
2,500 | $0 | 146,235 (Direct) |
View |
2021-06-28 Exercise |
2021-06-30 4:11 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | ROBERTSON MICHELLE Chief Financial Officer |
2,500 | $30.65 | 146,235 (Direct) |
View |
2021-06-14 Option Award |
2021-06-16 4:20 pm |
N/A 2031-03-01 |
Editas Medicine Inc. | EDIT | MULLEN JAMES C CEO |
170,989 | $0 | 170,989 (Direct) |
View |
2021-06-14 Option Award |
2021-06-16 4:19 pm |
N/A 2031-06-13 |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer |
85,419 | $0 | 85,419 (Direct) |
View |
Ownership |
2021-06-16 4:18 pm |
N/A N/A |
Editas Medicine Inc. | EDIT | Shearman Mark S EVP, Chief Scientific Officer |
0 | $0 | 0 (Direct) |
View |
2021-06-03 Option Award |
2021-06-07 4:16 pm |
N/A 2031-06-02 |
Editas Medicine Inc. | EDIT | Vaishnaw Akshay Director |
11,538 | $0 | 11,538 (Direct) |
View |
2021-06-03 Option Award |
2021-06-07 4:14 pm |
N/A 2031-06-02 |
Editas Medicine Inc. | EDIT | Scadden David Director |
11,538 | $0 | 11,538 (Direct) |
View |
2021-06-03 Option Award |
2021-06-07 4:13 pm |
N/A 2031-06-02 |
Editas Medicine Inc. | EDIT | Chatterjee Meeta Director |
11,538 | $0 | 11,538 (Direct) |
View |
2021-06-03 Option Award |
2021-06-07 4:11 pm |
N/A 2031-06-02 |
Editas Medicine Inc. | EDIT | Hirsch Andrew Director |
11,538 | $0 | 11,538 (Direct) |
View |
2021-06-03 Option Award |
2021-06-07 4:09 pm |
N/A 2031-06-02 |
Editas Medicine Inc. | EDIT | Hopfield Jessica Director |
11,538 | $0 | 11,538 (Direct) |
View |